797PDLATITUDE study: PSA response characteristics and correlation with overall survival (OS) and radiological progression-free survival (rPFS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving ADT+abiraterone acetate and prednisone (AAP) or placebo (PBO)
Matsubara, N, Chi, K N, Ozguroglu, M, Rodriguez Antolin, A, Feyerabend, S, Fein, L, Alekseev, B Y, Sulur, G, Protheroe, A, Li, S, Mundle, S D, De Porre, P, Tran, N, Fazazi, KVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy284.006
Date:
October, 2018
File:
PDF, 99 KB
english, 2018
File converter
More search results
More benefits 
